Enfuvirtide FDA Link

A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS.

Also Known As:

Fuzeon; DP 178; DP-178; DP178; Pentafuside; Peptide T20; T20 Peptide; T20, Peptide

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Membrane Proteins: 10262
    - Membrane Fusion Proteins: 7
      - Viral Fusion Proteins: 35
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 195
  - Viral Proteins: 4356
    - Viral Antigens: 3282
      - HIV Antigens: 144
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 195
    - Viral Structural Proteins: 173
      - Viral Envelope Proteins: 297
        env Gene Products: 219
        Human Immunodeficiency Virus env Gene Products
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 195
        Viral Fusion Proteins: 35
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 195
    - Retroviridae Proteins: 7
      - env Gene Products: 219
        Human Immunodeficiency Virus env Gene Products
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 195
      - Human Immunodeficiency Virus Proteins: 146
        Human Immunodeficiency Virus env Gene Products
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 195
- Peptides: 84029
  - Peptide Fragments: 379
    - Enfuvirtide: 195
Biological Factors: 2560
- Antigens: 145631
  - Viral Antigens: 3282
    - HIV Antigens: 144
      - HIV Envelope Protein gp41: 6
        Enfuvirtide: 195

Mei Shan Selected Research

Mei Shan Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure